U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06937385) titled '0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment' on April 15.
Brief Summary: Headache is a frequent chief complaint among patients presenting to the Emergency Department (ED), accounting for 2.1 million visits annually in the United States (McCraig, 2005; Cephalalgia, 2006). Often, individuals resort to ED care only after over-the-counter or home remedies have failed, leading to the predominant use of intravenous (IV) medications in the ED, including NSAIDs, triptans, neuroleptics, antiepileptics, and dopaminergic antagonists. Unfortunately, these pharmacologic treatments frequently ...